[HTML][HTML] Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb, S Chagnon-Monarque… - Radiation …, 2019 - Springer
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
[PDF][PDF] Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb, S Chagnon-Monarque… - 2019 - scholar.archive.org
Background: Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
[HTML][HTML] Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb… - Radiation Oncology …, 2019 - ncbi.nlm.nih.gov
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
[HTML][HTML] Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb… - Radiation …, 2019 - ro-journal.biomedcentral.com
Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of recurrence and
survival with particular treatment response, yet no study has tested its response to …
survival with particular treatment response, yet no study has tested its response to …
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.
VQ Trinh, N Benzerdjeb… - Radiation Oncology …, 2019 - europepmc.org
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.
VQ Trinh, N Benzerdjeb… - Radiation …, 2019 - search.ebscohost.com
Abstract < bold> Background: </bold> Intraductal carcinoma of the prostate (IDC-P)
is an independent biomarker of recurrence and survival with particular treatment response …
is an independent biomarker of recurrence and survival with particular treatment response …
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb… - Radiation …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb… - Radiation …, 2019 - search.proquest.com
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
VQ Trinh, N Benzerdjeb, S Chagnon-Monarque… - Radiation …, 2019 - go.gale.com
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.
VQ Trinh, N Benzerdjeb… - Radiation Oncology …, 2019 - europepmc.org
Background Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of
recurrence and survival with particular treatment response, yet no study has tested its …
recurrence and survival with particular treatment response, yet no study has tested its …